MDS Pharma Services’ early clinical research and clinical pharmacology operations in Belfast, Northern Ireland, and its clinical pharmacology and bioanalytical services operation in Lincoln, Nebraska, have been certified by Brazil’s regulatory agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA).

 “MDS Pharma Services is the only contract research organization in the UK, and one of only two in the U.S., to offer clients the benefits of ANVISA certification,” said MDS Pharma Services President David Spaight.

 In addition to ANVISA certification, the MDS Pharma Services facilities have also been certified by the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) and the World Health Organization (WHO).